Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus

The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health. Vaccines are ideal solutions to prevent infection, but treatments are also needed for those who have contracted the virus to limit negative outcomes, when vaccin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Biol Chem
Autori principali: Vitner, Einat B., Achdout, Hagit, Avraham, Roy, Politi, Boaz, Cherry, Lilach, Tamir, Hadas, Yahalom-Ronen, Yfat, Paran, Nir, Melamed, Sharon, Erez, Noam, Israely, Tomer
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Biochemistry and Molecular Biology 2021
Soggetti:
Accelerated Communication
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904475/
https://ncbi.nlm.nih.gov/pubmed/33639165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbc.2021.100470
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi